求几篇文献，谢谢！！

liutianzhu

Title: CD133: molecule of the moment.
$ s* t* f0 f1 g, E6 k$ PAuthor: Mizrak, D.; Brittan, M.; Alison, M. R.: u6 R4 n  f1 W7 o- [
Source: J Pathol, 2008, 214(1): 3-9
$ d+ Y4 X& y& U. c  k% b+ j" G6 X: Q( E$ n: y. J; ~0 `
Title: Focus on molecules: prominin-1 (CD133).
2 A. l  i# B2 t1 D4 F% Y  KAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)( Y/ D' h! f1 n9 e/ J1 \9 _
Source: Exp Eye Res, 2007, 85(5): 585-586# ^' W7 B6 s: b- r

: x9 d- b0 A' m1 o  nTitle: CD133.
7 X* I& ~6 U" c" `6 c! y' ~6 X9 ^Author: Piechaczek, C.8 [  U( D! A' W/ F
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-102" }3 }! d. Y  z, J' ~  o: C! m6 f9 s
3 V$ f5 d! U' j! Q; B  J# X$ m( b
Title: CD133 as a marker for cancer stem cells: progresses and concerns.
7 c; }7 ]; k2 C2 U% P# V( GAuthor: Wu, Y.; Wu, P. Y.
! ~! J% b2 r# `# l" j( M2 P" oSource: Stem Cells Dev, 2009, 18(8): 1127-1134
% k% U( O6 W' A+ u  W' I( `2 I8 u9 l" N6 G
Title: Risk and benefit of CD133+ progenitors.7 P) e7 A2 D! y/ |
Author: Ascione, R.; Madeddu, P.0 W4 U6 v' N; r
Source: Circ Res, 2009, 105(2): e2' Q2 L# ^9 J! W

# k8 z- f- t; ^6 D+ W7 a$ V) XTitle: Targeting CD133 antigen in cancer.
, v! L* k% |+ @/ c0 G# Y- k2 A+ mAuthor: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...); o; I: V. R8 G
Source: Expert Opin Ther Targets, 2009, 13(7): 823-8370 [: a; n5 P, z, k

. I9 q& X! v1 r7 ~, |$ VTitle: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
( {! f* H7 a* U8 IAuthor: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)
" D' t& q* R% |4 pSource: Neurosurgery, 2008, 62(2): 505-514, 514-515

dahui

111111111111

dahui

dahui

22222222

lingn

4# f& d; w2 L0 l

平步

是这篇吧

baixueyao029

回复 6# 平步 8 g/ v2 l  w# F/ H; {, T1 n7 }) ?
7 b) C; |0 [; Z1 R7 S
麻烦标出这事哪一篇？

laolifeidao999

5.Risk and benefit of CD133+ progenitors.

laolifeidao999

7.Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.

平步

CD133 as a Marker for Cancer Stem Cellsrogresses and Concerns不好意思，没看到楼上的已经发了这一篇